Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus-negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease

被引:32
作者
Griffith, DE [1 ]
Brown, BA [1 ]
Wallace, RJ [1 ]
机构
[1] UNIV TEXAS,CTR HLTH,CTR PULM INFECT DIS CONTROL,DEPT MICROBIOL,TYLER,TX 75710
关键词
D O I
10.1093/clinids/23.6.1321
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
[No abstract available]
引用
收藏
页码:1321 / 1322
页数:2
相关论文
共 3 条
[1]   ADVERSE EVENTS ASSOCIATED WITH HIGH-DOSE RIFABUTIN IN MACROLIDE-CONTAINING REGIMENS FOR THE TREATMENT OF MYCOBACTERIUM-AVIUM COMPLEX LUNG-DISEASE [J].
GRIFFITH, DE ;
BROWN, BA ;
GIRARD, WM ;
WALLACE, RJ .
CLINICAL INFECTIOUS DISEASES, 1995, 21 (03) :594-598
[2]  
OBRIEN RJ, 1987, REV INFECT DIS, V9, P519
[3]   PHARMACOKINETIC DRUG-INTERACTIONS OF MACROLIDES [J].
PERITI, P ;
MAZZEI, T ;
MINI, E ;
NOVELLI, A .
CLINICAL PHARMACOKINETICS, 1992, 23 (02) :106-131